Clinical trial
A Study of RSLV-132 in Subjects With Primary Sjogren's Syndrome
NCT03247686
Study timeline
Study start (actual)2017-02-01Date precision: day
Registry last updated2021-04-02
Observed by CureCurrent2026-10-07
Recorded dates are source observations, not predictions. Missing milestones are not estimated.
Conditions
Sjogren's Syndromeunresolved
Interventions
Sponsors & collaborators
Resolve Therapeuticslead sponsor
University Hospital Birminghamcollaborator
Newcastle-upon-Tyne Hospitals NHS Trustcollaborator
Registry source
Open the source record to verify current eligibility, contacts, locations and registry updates.
Open NCT03247686 on ClinicalTrials.gov ↗Registry-derived research relationships: ClinicalTrials.gov. Raw condition and intervention labels remain distinct from canonical MONDO/RxNorm entities unless separately normalized.